Compare New York Times Co (NYT) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
New York Times Co vs TransMedics Group Inc — how do they compare? New York Times Co trades at $75.56 (market cap $12.29B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: New York Times Co is far larger — about 4.8× TransMedics Group Inc's market cap, and New York Times Co pays a 1.21% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NYT | TMDX | |
|---|---|---|
Market Cap | $12.29B | $2.54B |
Sector | Media | Technology |
52-Week High | $85.86 | $150.42 |
52-Week Low | $51.43 | $61.99 |
Enterprise Value | $11.68B | $2.94B |
Dividend Yield | 1.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About New York Times Co
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
